CNBC’s Meg Tirrell tweeted a statement from Pfizer in response to an earlier tweet sent from U.S. President Donald Trump about drug prices. “The list price remains unchanged for the majority of our medicines,” Pfizer said. “Our portfolio includes more than 400 medicines and vaccines; we are modifying prices for approximately 10% of these, including some instances where we’re decreasing the price. Importantly, list prices do not reflect what most patients or insurance companies pay. In the first quarter of 2018 the net selling price increase was 0% due to the growing amount of rebates paid back to stakeholders in the biopharmaceutical supply chain.”
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.